Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas<sup>®</sup> HBV Test for Use on the Cobas<sup>®</sup> 4800 System

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas<sup>®</sup> HBV Test for Use on the Cobas<sup>®</sup> 4800 System

(1) Background: Sensitive and accurate nucleic acid amplification technologies are now recommended for hepatitis B virus (HBV) DNA detection and quantification in clinical practice to diagnose and monitor hepatitis B infection. The aim of this study was to assess the analytical and clinical performa...

Full description

Bibliographic Details
Main Authors:	Valérie Ortonne, Mélanie Wlassow, Magali Bouvier-Alias, Giovana Melica, Jean-Dominique Poveda, Syria Laperche, Jean-Michel Pawlotsky, Stephane Chevaliez
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Microorganisms
Subjects:	hepatitis B virus HBV DNA HBV monitoring real-time PCR hepatitis B infection diagnosis
Online Access:	https://www.mdpi.com/2076-2607/9/3/573

Similar Items

Multicenter Evaluation of the Cepheid Xpert<sup>®</sup> HBV Viral Load Test
by: Fabbio Marcuccilli, et al.
Published: (2021-02-01)

An in-house real-time polymerase chain reaction: standardisation and comparison with the Cobas Amplicor HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the quantification of hepatitis B virus DNA
by: Ana Paula de Torres Santos, et al.
Published: (2016-02-01)

HBV genotypes and antiviral therapy of hepatitis B
by: I.A. Zaitsev, et al.
Published: (2019-09-01)

Real-time PCR per HBV DNA: valutazione del nuovo sistema automatizzato COBAS AMPLIPREP™/COBAS TAQMAN™ HBV
by: Tiziano Allice, et al.
Published: (2007-12-01)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
by: Yeping Sun, et al.
Published: (2018-09-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Comparison of HBV-DNA Levels with Biochemical and Microbiological Parameters for Chronic Hepatitis Evaluation, Bursa, Turkey
by: Sanem Karadag Gecgel
Published: (2021-03-01)

Seroprevalence of HBV and HCV markers among young adult males in the Air Force in Florianópolis, South Brazil
by: Ana Maria Passos, et al.
Published: (2012-06-01)

HBV-DNA in hemodialysis patients infected by HCV
by: Arababadi Mohammad, et al.
Published: (2009-01-01)

Hepatitis B virus (HBV) genotype and its correlation with Hepatocellular carcinoma
by: Phan Quoc Viet, et al.
Published: (2016-03-01)

Comparison of serum hepatitis B virus replication markers in patients with chronic hepatitis B: studies on HBeAg/Anti-HBe system, viral dna polymerase and HBV-DNA Comparação dos marcadores sorológicos da replicação do vírus da hepatite B: estudos sobre o sistema AgHBe/anti-HBe, DNA polimerase virai e HBV-DNA
by: João Renato Rebello Pinho, et al.
Published: (1989-10-01)

The function of HBx in HBV-induced hepatocellular carcinoma
by: Lu Zhaoliang
Published: (2018-04-01)

HBV genotype distribution and its relationship with serum HBV DNA level and HBeAg expression among patients with chronic hepatitis B in southern Zhejiang Province, China
by: ZHOU Lianlian
Published: (2014-10-01)

HBV profile of the occult HBV infection in blood donors at Maharaj Nakorn Chiang Mai Hospital
by: Nipapan Leetrakool, et al.
Published: (2013-01-01)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
by: Xiaomei Wang, et al.
Published: (2021-01-01)

Risk stratification of HBV infection in Asia-Pacific region
by: Jia-Horng Kao
Published: (2014-09-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
by: Byung-Cheol Song, et al.
Published: (2014-12-01)

Serological markers and risk factors related to hepatitis B virus in dentists in the Central West region of Brazil Marcadores sorológicos e fatores de risco relacionados ao vírus da hepatite B em dentistas da região Centro Oeste do Brasil
by: Enilza Maria Mendonça de Paiva, et al.
Published: (2008-06-01)

MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B
by: I. P. Balmasova, et al.
Published: (2016-04-01)

Recent Advances in Hepatitis B Treatment
by: Georgia-Myrto Prifti, et al.
Published: (2021-05-01)

Chronic Active Hepatitis B with HBV-Associated Nephropathy: Close Resemblance to Lupus Nephritis
by: Amitesh Aggarwal, et al.
Published: (2014-04-01)

INSIGHTS INTO THE INTERPLAY BETWEEN KIR GENE FREQUENCIES AND CHRONIC HBV INFECTION IN BURKINA FASO
by: Abel Pegdwendé SORGHO, et al.
Published: (2018-11-01)

Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
by: Lazarević Ivana, et al.
Published: (2014-01-01)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
by: Giuseppe Gentile, et al.
Published: (2019-11-01)

Liver-Resident Memory CD8<sup>+</sup> T Cells: Possible Roles in Chronic HBV Infection
by: Ji Won Han, et al.
Published: (2021-12-01)

Mutational Analysis of HBs Ag-Positive Mothers and Their Infected Children despite Immunoprophylaxis
by: Azam Ghaziasadi, et al.
Published: (2013-12-01)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
by: Yu. V. Ostankova, et al.
Published: (2018-01-01)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Jolynne Mokaya, et al.
Published: (2019-06-01)

Justification for screening programs for early detection of HBV infections
by: Małgorzata Leźnicka, et al.
Published: (2014-12-01)

Expression of CD39 on FoxP3<sup>+ </sup>T regulatory cells correlates with progression of HBV infection
by: Tang Yan, et al.
Published: (2012-04-01)

Low Viral Load Does Not Exclude Significant Liver Damage in Patients with Chronic HBV Infection in Bangladesh
by: Mamun Al-Mahtab, et al.
Published: (2009-11-01)

Quantification of hepatitis B virus (HBV) DNA and HBV genotyping simultaneously in plasma using real-time polymerase chain reaction
by: Woottichai Khamduang, et al.
Published: (2018-08-01)

The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
by: Chul S. Hyun, et al.
Published: (2019-05-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Is Quantitative HBsAg Measurement a Reliable Substitute for HBV DNA Quantitation?
by: Mohammad Reza Mahdavi, et al.
Published: (2015-07-01)

Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
by: Angélica Luciana Nau, et al.
Published: (2014-04-01)

Surveillance and response of hepatitis B in Hong Kong Special Administrative Region, 1988–2014
by: Ada Wai-Chi Lin, et al.
Published: (2016-02-01)

Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil
by: Marinilde Teles Souza, et al.

Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil
by: Marinilde Teles Souza, et al.
Published: (2012-12-01)

Using the Quantitative Determination of HBsAg to Monitor the Natural History of Chronic HBV-Infection
by: I.A. Zaitsev
Published: (2015-09-01)

Cannot write session to /tmp/vufind_sessions/sess_r2i0hfac04abdr02gvivahcbjd